Key facts
- It has raised $16.4M; the latest was Later Stage VC ($200K) in Jun 2024.
- Notable investors include Keiretsu Forum, Ripple Impact Investments, Elevate Capital, WRF Capital, Caygan Capital — 22 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 22 names
- ·Watchlist + deal alerts for microMend
- ·The full record, as it builds
Funding rounds
No funding rounds for microMend are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About microMend
Developer of wound closure product designed to offer a new alternative to sutures and staples for skin closure. The company's product has the added feature of tiny micro staples that assist it in achieving similar holding strength to sutures and close wounds, enabling medical practitioners to close surgical incisions, lacerations and skin tears.
- Sector
- Healthcare
- HQ
- Seattle, WA, United States
- Employees
- 10
- Website
- micromendskinclosure.com/
- Ownership
- Privately Held (backing)
microMend doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in microMend shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on microMend in its N-PORT filings yet. We sweep new filings monthly.